000 | 01880 a2200565 4500 | ||
---|---|---|---|
005 | 20250515194503.0 | ||
264 | 0 | _c20100104 | |
008 | 201001s 0 0 eng d | ||
022 | _a1475-2875 | ||
024 | 7 |
_a10.1186/1475-2875-8-258 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVan Geertruyden, Jean-Pierre | |
245 | 0 | 0 |
_aThe relationship of Plasmodium falciparum humeral immunity with HIV-1 immunosuppression and treatment efficacy in Zambia. _h[electronic resource] |
260 |
_bMalaria journal _cNov 2009 |
||
300 |
_a258 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Protozoan _xblood |
650 | 0 | 4 |
_aAntigens, Protozoan _ximmunology |
650 | 0 | 4 |
_aAntigens, Surface _ximmunology |
650 | 0 | 4 |
_aAntimalarials _xpharmacology |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 |
_aHIV-1 _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunocompromised Host |
650 | 0 | 4 |
_aImmunoglobulin G _xblood |
650 | 0 | 4 |
_aMalaria, Falciparum _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMerozoite Surface Protein 1 _ximmunology |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlasmodium falciparum _ximmunology |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
650 | 0 | 4 | _aZambia |
700 | 1 | _aVan Eijk, Erika | |
700 | 1 | _aYosaatmadja, Francisca | |
700 | 1 | _aKasongo, Webster | |
700 | 1 | _aMulenga, Modest | |
700 | 1 | _aD'Alessandro, Umberto | |
700 | 1 | _aRogerson, Stephen | |
773 | 0 |
_tMalaria journal _gvol. 8 _gp. 258 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1475-2875-8-258 _zAvailable from publisher's website |
999 |
_c19308050 _d19308050 |